France's Ramsay Sante's Q1 revenue rises on French hospital admissions, Nordic strength
Overview
France-based private hospital operator's Q1 revenue rose 2.9% yr/yr on higher French hospital admissions and Nordic strength
Q1 EBITDA increased 7.5%, outpacing revenue growth due to operational improvements and cost control
Q1 net loss narrowed from prior year
Outlook
Company expects FY 2027 revenue growth between 2.0% and 3.0% and stable EBITDA margin
Company targets FY 2029 revenue growth of about 3.0% per year and gradual EBITDA margin improvement
Ramsay Santé expects gross capex at about 4.0% of revenue on average over FY 2027-2029 period
Result Drivers
ADMISSIONS AND NORDIC GROWTH - Co said Q1 revenue was driven by higher French hospital admissions, day medicine care development, Nordic strength and St Göran contract
COST CONTROL - Co said strengthened productivity and cost-control initiatives offset inflation and improved EBITDA margin
Company press release:
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q1 Revenue | EUR 1.23 bln | ||
Q1 Net Loss | EUR 35.5 mln | ||
Q1 EBITDA | EUR 120.7 mln |
Analyst Coverage
The stock recently traded at 12 times the next 12-month earnings vs. a P/E of 15 three months ago
Reuters Recommended Reads
Nov 4 - Sweden's Medicover Q3 profit rises 29% on price adjustments and wider network; to focus on Europe
Nov 4 - Healthcare firm Fresenius Q3 revenue rises on Kabi growth; lifts outlook
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)